Company / Shares Outstanding
Theravance Biopharma, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
49.5M
FY2025
5-year range
48.1M / 74.4M
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#168 of 212
Health Care
What the data says
Theravance Biopharma, Inc.'s shares outstanding of 49471000.00 is lower than 79% of companies in the Health Care sector (FY2025). Shares Outstanding returned to growth in FY2025 after 2 years of decline, reaching 49471000.00.
Based on SEC 10-K filings.
49471000.00 in FY2025 with a 5-year CAGR of -2.8%.
Improved from 65227000.00 to 49471000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -12.7%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 212This company 49.5M Sector average 306.7M
▼
-83.9% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 2.9% year-over-year.
- Ranks #168 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 49.5M | +2.9% |
| FY2024 | 48.1M | -26.3% |
| FY2023 | 65.2M | -12.4% |
| FY2022 | 74.4M | +15.7% |
| FY2021 | 64.3M | +12.8% |
| FY2020 | 57.0M | +2.4% |
| FY2019 | 55.7M | +2.4% |
| FY2018 | 54.4M | +2.9% |
| FY2017 | 52.8M | +39.1% |
| FY2016 | 38.0M | +17.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026